دورية
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease : an interview with David A Schwartz, 13 June 2007
العنوان: | The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease : an interview with David A Schwartz, 13 June 2007 |
---|---|
المؤلفون: | Schwartz, David A |
المصدر: | Biologics, 2008; v.2 n.1:p.125-128 |
الوصول الحر: | https://ndhadeliver.natlib.govt.nz/delivery/DeliveryManagerServlet?dps_pid=FL1059246Test |
قاعدة البيانات: | Index New Zealand |